A patient-centric chest pain management approach utilizing a high sensitivity Troponin-I assay

Abby E Roetger1, Christopher D McKinney2, De B Winter Iii3

  • 1Institute of Safety and Quality, Novant Health, Wilmington, N.C., USA.

Heliyon
|November 5, 2024
PubMed

Insights

Implementing a new high-sensitivity troponin I (hs-cTnI) pathway in the emergency department improved efficiency for chest pain patients. This standardized approach demonstrated safety with no increase in major adverse cardiac events.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Pathway Development

Background:

  • Evaluating patients with chest pain in the emergency department (ED) requires efficient and accurate diagnostic tools.
  • Traditional troponin assays and non-standardized approaches can lead to variable patient disposition and resource utilization.

Purpose of the Study:

  • To assess the impact of adopting a new cardiac chest pain pathway incorporating high-sensitivity troponin I (hs-cTnI) testing in the ED.
  • To evaluate the effect of this standardized pathway on patient disposition, length of stay, and clinical outcomes.

Main Methods:

  • A retrospective observational study compared patients presenting with chest pain before and after the implementation of a new pathway.
  • The new pathway included hs-cTnI testing (Seimens Healthineers Atellica) and risk stratification tools.
  • Bivariate analyses compared outcomes, including discharge disposition, length of stay, and cardiac catheterization rates.

Main Results:

  • The proportion of patients discharged from the ED increased, while observation or in-patient admissions decreased.
  • Provider variation in patient disposition reduced, and stress testing rates for observed patients decreased.
  • No significant change in 30-day Major Adverse Cardiac Events (MACE) was observed, but the 30-day Myocardial Infarction (MI) rate decreased.

Conclusions:

  • The new standardized hs-cTnI algorithm approach is safe, with no increase in 30-day MACE.
  • This pathway is more appropriate and efficient for evaluating chest pain patients in the ED compared to previous non-standardized methods.
Abstract

Related Concept Videos

Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
2
Pericarditis II: Clinical features and Diagnostic Tests01:19

Pericarditis II: Clinical features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
3
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
142
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
299
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2